India surges to lead in generics

More proof that India is the new headwaters of generic drug-making: Watson Pharmaceuticals got the FDA to sign off on its production facility in Goa, India.
The California-based company didn't say which product or products it plans to make there, but did project that, by early 2008, it will be on pace to turn out 1 billion tablets and capsules there annually--all for sale on the U.S. market.

- check out the release on the new facility 
- here's more from Forbes

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.